Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV Aged ≥ 65 Years: Week 48 Results of a Phase 3b, Open-Label Trial

  1. Maggiolo, F.
  2. Rizzardini, G.
  3. Molina, J.-M.
  4. Pulido, F.
  5. De Wit, S.
  6. Vandekerckhove, L.
  7. Berenguer, J.
  8. D’Antoni, M.L.
  9. Blair, C.
  10. Chuck, S.K.
  11. Piontkowsky, D.
  12. Martin, H.
  13. Haubrich, R.
  14. McNicholl, I.R.
  15. Gallant, J.
Journal:
Infectious Diseases and Therapy

ISSN: 2193-6382 2193-8229

Year of publication: 2021

Volume: 10

Issue: 2

Pages: 775-788

Type: Article

DOI: 10.1007/S40121-021-00419-5 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals